The relation between α-synuclein and microglia in Parkinson's disease: Recent developments

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Microglia activation is a common pathological finding in neurodegenerative diseases like Parkinson's disease (PD) and multiple system atrophy (MSA).
• Microglia maintain neuronal homeostasis, but their activation during disease can promote degeneration.
• Alpha-synuclein aggregation is central to PD and related disorders, with microglia being key players in its clearance.

Purpose of the Study:

• To review recent findings on the role of microglia in Parkinson's disease and other alpha-synucleinopathies.
• To highlight the importance of understanding microglia's response to alpha-synuclein accumulation.
• To explore the therapeutic potential of targeting microglia in neurodegenerative diseases.

Main Methods:

• Literature review of recent research on microglia and alpha-synuclein.
• Analysis of studies examining microglial activation in Parkinson's disease and related disorders.
• Synthesis of current knowledge on alpha-synuclein clearance by microglia.

Main Results:

• Microglia exhibit complex responses to alpha-synuclein, influencing disease progression.
• Microglia are central to the handling and clearance of extracellular alpha-synuclein.
• Microglial behavior significantly impacts neuronal survival or degeneration in alpha-synucleinopathies.

Conclusions:

• A deeper understanding of microglia's interaction with alpha-synuclein is essential for therapeutic development in PD and other alpha-synucleinopathies.
• Targeting microglial responses to pathological alpha-synuclein offers a promising therapeutic avenue.
• Further research into microglia's role across different disease stages and brain areas is warranted.